Nectero Medical

Nectero Therapeutics – Nectero Therapeutics is developing a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms (AAA).

Tempe, United States · Founded 2017 · $115.5M raised

Headquarters
Tempe, Arizona
Employees
11–50
Founded
2017
Business Model
B2B
Total Funding
$115.5M
Last Round
$96.0M Series DApr 2024
Rounds
2

About

Nectero Medical (now Nectero Therapeutics) is a clinical-stage biotech company developing the Nectero EAST® System, a minimally invasive endovascular procedure that delivers a stabilizing agent to strengthen the aortic wall and slow growth of small to medium-sized abdominal aortic aneurysms. The company received FDA Fast Track and Breakthrough Therapy designations in 2023 and raised a $94M Series D to advance its Phase II/III trial.

Summary

Nectero Medical is a Biotech company based in Tempe, United States, founded in 2017. It has raised $115.5M in total across 2 rounds, most recently a $96.0M Series D round in Apr 2024. Investors include Boston Scientific Corporation, Shiv Chaudhary and BioStar Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series DSeries DApr 2024
$96.0M

Sign up to see all 2 rounds

Series C through Series D — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Nectero Medical on Indexed.vc
<a href="https://indexed.vc/companies/nectero-medical"><img src="https://indexed.vc/api/badge/company/nectero-medical" alt="Nectero Medical on Indexed.vc" width="260" height="76" /></a>